Subanalysis of ADAPT Reveals Consistent Efficacy With Efgartigimod Among All Genders
Patients with generalized myasthenia gravis treated with efgartigimod consistently exceeded treatment compared with placebo regardless of gender in age, disease duration, body mass index, and thymectomy.
United States James Howard Sarah Hoffmann Equity In Research University Of North Carolina School Medicine Department Of Neurology
Source: ajmc.com